Literature DB >> 26463868

Temporary Ovarian Suppression With Gonadotropin-Releasing Hormone Agonist During Chemotherapy for Fertility Preservation: Toward the End of the Debate?

Lucia Del Mastro1, Matteo Lambertini2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26463868      PMCID： PMC4718439          DOI： 10.1634/theoncologist.2015-0373

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  15 in total

1.  Protecting Ovaries During Chemotherapy Through Gonad Suppression: A Systematic Review and Meta-analysis.

Authors:  Matteo Lambertini; Francesca Poggio; Alessia Levaggi; Lucia Del Mastro
Journal:  Obstet Gynecol       Date:  2015-10       Impact factor: 7.661

2.  Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  F A Peccatori; H A Azim; R Orecchia; H J Hoekstra; N Pavlidis; V Kesic; G Pentheroudakis
Journal:  Ann Oncol       Date:  2013-06-27       Impact factor: 32.976

3.  Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer.

Authors:  Joseph M Letourneau; Erin E Ebbel; Patricia P Katz; Audra Katz; Wei Z Ai; A Jo Chien; Michelle E Melisko; Marcelle I Cedars; Mitchell P Rosen
Journal:  Cancer       Date:  2011-09-01       Impact factor: 6.860

4.  Goserelin with chemotherapy to preserve ovarian function in pre-menopausal women with early breast cancer: menstruation and pregnancy outcomes.

Authors:  M Wong; S O'Neill; G Walsh; I E Smith
Journal:  Ann Oncol       Date:  2012-09-27       Impact factor: 32.976

5.  Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.

Authors:  Halle C F Moore; Joseph M Unger; Kelly-Anne Phillips; Frances Boyle; Erika Hitre; David Porter; Prudence A Francis; Lori J Goldstein; Henry L Gomez; Carlos S Vallejos; Ann H Partridge; Shaker R Dakhil; Agustin A Garcia; Julie Gralow; Janine M Lombard; John F Forbes; Silvana Martino; William E Barlow; Carol J Fabian; Lori Minasian; Frank L Meyskens; Richard D Gelber; Gabriel N Hortobagyi; Kathy S Albain
Journal:  N Engl J Med       Date:  2015-03-05       Impact factor: 91.245

6.  Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial.

Authors:  K Behringer; I Thielen; H Mueller; H Goergen; A D Eibl; J Rosenbrock; T Halbsguth; D A Eichenauer; M Fuchs; K S Reiners; J H Renno; K van der Ven; M Kuehr; M von Wolff; V Diehl; A Engert; P Borchmann
Journal:  Ann Oncol       Date:  2012-01-06       Impact factor: 32.976

7.  Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial.

Authors:  Lucia Del Mastro; Luca Boni; Andrea Michelotti; Teresa Gamucci; Nina Olmeo; Stefania Gori; Monica Giordano; Ornella Garrone; Paolo Pronzato; Claudia Bighin; Alessia Levaggi; Sara Giraudi; Nicola Cresti; Emanuela Magnolfi; Tiziana Scotto; Carlo Vecchio; Marco Venturini
Journal:  JAMA       Date:  2011-07-20       Impact factor: 56.272

Review 8.  Strategies for fertility preservation in young early breast cancer patients.

Authors:  Nicoletta Tomasi-Cont; Matteo Lambertini; Sofie Hulsbosch; Alessandro Fedro Peccatori; Frederic Amant
Journal:  Breast       Date:  2014-06-13       Impact factor: 4.380

Review 9.  Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update.

Authors:  Alison W Loren; Pamela B Mangu; Lindsay Nohr Beck; Lawrence Brennan; Anthony J Magdalinski; Ann H Partridge; Gwendolyn Quinn; W Hamish Wallace; Kutluk Oktay
Journal:  J Clin Oncol       Date:  2013-05-28       Impact factor: 44.544

Review 10.  Fertility preservation in women with cancer.

Authors:  Michel De Vos; Johan Smitz; Teresa K Woodruff
Journal:  Lancet       Date:  2014-10-04       Impact factor: 79.321
View more
  7 in total

1.  Is there a robust future for research in reproduction?

Authors:  Christopher L R Barratt
Journal:  Mol Hum Reprod       Date:  2015-11-20       Impact factor: 4.025

2.  A grafted ovarian fragment rescues host fertility after chemotherapy.

Authors:  Iordan Stefanov Batchvarov; Rachel Williamson Taylor; Ximena Bustamante-Marín; Michael Czerwinski; Erika Segear Johnson; Sally Kornbluth; Blanche Capel
Journal:  Mol Hum Reprod       Date:  2016-10-03       Impact factor: 4.025

Review 3.  Ovarian Function Suppression in Premenopausal Women with Early-Stage Breast Cancer.

Authors:  Matteo Lambertini; Lucia Del Mastro; Giulia Viglietti; Noam F Pondé; Cinzia Solinas; Evandro de Azambuja
Journal:  Curr Treat Options Oncol       Date:  2017-01

Review 4.  Perspectives on the co-treatment with GnRHa in female patients undergoing hematopoietic stem cell transplantation.

Authors:  Luminita Nicoleta Cima; Anca Colita; Simona Fica
Journal:  Endocr Connect       Date:  2017-09-25       Impact factor: 3.335

Review 5.  Fertility Preservation Using GnRH Agonists: Rationale, Possible Mechanisms, and Explanation of Controversy.

Authors:  Zeev Blumenfeld
Journal:  Clin Med Insights Reprod Health       Date:  2019-08-21

Review 6.  Burning Questions in the Oncofertility Counseling of Young Breast Cancer Patients.

Authors:  Luca Arecco; Marta Perachino; Alessandra Damassi; Maria Maddalena Latocca; Davide Soldato; Giacomo Vallome; Francesca Parisi; Maria Grazia Razeti; Cinzia Solinas; Marco Tagliamento; Stefano Spinaci; Claudia Massarotti; Matteo Lambertini
Journal:  Breast Cancer (Auckl)       Date:  2020-09-04

Review 7.  Gender-specific aspects related to type of fertility preservation strategies and access to fertility care.

Authors:  Marta Perachino; Claudia Massarotti; Maria Grazia Razeti; Francesca Parisi; Luca Arecco; Alessandra Damassi; Piero Fregatti; Cinzia Solinas; Matteo Lambertini
Journal:  ESMO Open       Date:  2020-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.